Literature DB >> 11397947

Guidelines for the referral and management of patients eligible for solid organ transplantation.

T I Steinman1, B N Becker, A E Frost, K M Olthoff, F W Smart, W N Suki, A H Wilkinson.   

Abstract

Members of the Clinical Practice Committee, American Society of Transplantation, have attempted to define referral criteria for solid organ transplantation. Work done by the Clinical Practice Committee does not represent the official position of the American Society of Transplantation. Recipients for solid organ transplantation are growing in numbers, progressively outstripping the availability of organ donors. As there may be discrepancies in referral practice and, therefore, inequity may exist in terms of access to transplantation, there needs to be uniformity about who should be referred to transplant centers so the system is fair for all patients. A review of the literature that is both generic and organ specific has been conducted so referring physicians can understand the criteria that make the patient a suitable potential transplant candidate. The psychosocial milieu that needs to be addressed is part of the transplant evaluation. Early intervention and evaluation appear to play a positive role in maximizing quality of life for the transplant recipient. There is evidence, especially in nephrology, that the majority of patients with progressive failure are referred to transplant centers at a late stage of disease. Evidence-based medicine forms the basis for medical decision-making about accepting the patient as a transplant candidate. The exact criteria for each organ are detailed. These guidelines reflect consensus opinions, synthesized by the authors after extensive literature review and reflecting the experience at their major transplant centers. These guidelines can be distributed by transplant centers to referring physicians, to aid them in understanding who is potentially an acceptable candidate for transplantation. The more familiar physicians are with the exact criteria for specific organ transplantation, the more likely they are to refer patients at an appropriate stage. Individual transplant centers will make final decisions on acceptability for transplantation based on specific patient factors. It is hoped that this overview will assist insurers/payors in reimbursing transplant centers for solid organ transplantation, based on criteria for acceptability by the transplant community. The selection and management of patients with end-stage organ failure are constantly changing, and future advances may make obsolete some of the criteria mentioned in the guidelines. Most importantly, these are intended to be guidelines, not rules.

Entities:  

Mesh:

Year:  2001        PMID: 11397947     DOI: 10.1097/00007890-200105150-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  22 in total

1.  Sacral neuromodulation enabling simultaneous pancreas and kidney transplantation: a first case.

Authors:  Donatella Pistolesi; Massimiliano Barsotti; Gianluca Giannarini; Mauro Mantovani; Ugo Boggi; Thomas M Kessler; Cesare Selli
Journal:  BMJ Case Rep       Date:  2009-02-02

2.  Management of liver cirrhosis between primary care and specialists.

Authors:  Ignazio Grattagliano; Enzo Ubaldi; Leonilde Bonfrate; Piero Portincasa
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

3.  Cyclic AMP prolongs graft survival by suppressing apoptosis and inflammatory gene expression in acute cardiac allograft rejection.

Authors:  Jie-Young Lee; Jung Hwan Kim; Gibong Chae; Bong-Ki Lee; Kwon-Soo Ha; Young-Geun Kwon; Young-Myeong Kim
Journal:  Exp Mol Med       Date:  2010-01-31       Impact factor: 8.718

4.  Disparities in symptom burden and renal transplant eligibility: a pilot study.

Authors:  Nathaniel Berman; Kaylan Christianer; Jordan Roberts; Rachel Feldman; M Cary Reid; Rouzi Shengelia; Jeanne Teresi; Joseph Eimicke; Brian Eiss; Ronald Adelman
Journal:  J Palliat Med       Date:  2013-10-10       Impact factor: 2.947

5.  How to demonstrate the reversibility of end-organ function before implantation of left ventricular assist device in INTERMACS profile 2 patients?

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Taro Shiga; Naoko Kato; Miyoko Endo; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Atsushi Yao; Yasunobu Hirata; Masaaki Akahane; Takashi Nishimura; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  J Artif Organs       Date:  2012-07-17       Impact factor: 1.731

Review 6.  Ethical issues associated with solid organ transplantation and substance use: a scoping review.

Authors:  Lauren Notini; Denitsa Vasileva; Ani Orchanian-Cheff; Daniel Z Buchman
Journal:  Monash Bioeth Rev       Date:  2019-12

Review 7.  The start of the transplant journey: referral for pediatric solid organ transplantation.

Authors:  Diana Shellmer; Cheryl Brosig; Jo Wray
Journal:  Pediatr Transplant       Date:  2014-01-20

Review 8.  Depression and Anxiety as Risk Factors for Morbidity and Mortality After Organ Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Mary Amanda Dew; Emily M Rosenberger; Larissa Myaskovsky; Andrea F DiMartini; Annette J DeVito Dabbs; Donna M Posluszny; Jennifer Steel; Galen E Switzer; Diana A Shellmer; Joel B Greenhouse
Journal:  Transplantation       Date:  2015-05       Impact factor: 4.939

Review 9.  Treatment of hepatitis C in solid organ transplantation.

Authors:  Susan E Chan; Jonathan M Schwartz; Hugo R Rosen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage.

Authors:  Nicole M Martin; Barham K Abu Dayyeh; Raymond T Chung
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.